Results 31 to 40 of about 8,099 (196)

Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus [PDF]

, 2021
Item does not contain fulltextBACKGROUND AND PURPOSE: Between 30% and 47% of patients treated with definitive radiotherapy (RT) for prostate cancer are at risk of intraprostatic recurrence during follow-up. Re-irradiation with stereotactic body RT (SBRT)
Janoray G., Corso, F, Zilli T., Pepa, M., Hannoun-Levi J. -M., Miralbell, R, Bari, B. De, Loi, Mauro, Bossi, Alberto, Franzese, Ciro, Vavassori A., Pasquier D., Pinkawa, Michael, on the behalf of the European Society for Radiotherapy, Oncology Advisory Committee on Radiation Oncology Practice (ESTRO ACROP),, Hannoun-Levi, Jean-Michel, Scorsetti, M., Cornford P., Corso, F., Tree, Alison, Kerkmeijer, Linda, Pepa, Matteo, Miralbell R., Livi, Lorenzo, Fonteyne, V., Scorsetti, M, Pieters, Bradley, Kwok, Y, Vavassori, A, Bossi, A., Cornford, Philip, Tree, AC, Zerini, Dario, Alongi, Filippo, Ost, P, Marvaso G., Gugliandolo, SG, Cornford, P., Toledano, Alain, Scorsetti, Marta, Pieters, Bradley R, Shelan, M., Fonteyne V., Gandini, S, Shelan, Mohamed, Zaffaroni, M, Livi L., Loi M., Arcangeli, S., Zerini, D., Hannoun-Levi, J.M., Corso, Federica, Gandini S., Toledano, A., Ost P., Alongi, F., Hoskin, P, Kerkmeijer, L., Jereczek-Fossa, Barbara A., Fuller, D.B., Jereczek-Fossa, B.A., Pepa, M, Hannoun-Levi, J-M, Hoskin, P., Gugliandolo, Simone Giovanni, Ost, Piet, Fonteyne, Valérie, Kwok Y., Livi, L, Cornford, P, Jereczek-Fossa B. A., Ost, P., Loi, M., Hoskin P., Tree, Alison C, van As, Nicholas, Zaffaroni M., Kwok, Y., Jereczek-Fossa, Barbara, Kerkmeijer, L, Loi, M, Bossi A., Pasquier, David, Corso F., Fonteyne, V, Janoray, G, De Bari, Berardino, Livi, L., Pieters B. R., Fuller, Donald, Gandini, Sara, Fuller D. B., Pasquier, D., van As, N, van As, N., Kwok, Young, Pinkawa M., Shelan M., Jereczek-Fossa, Barbara A, Zaffaroni, Mattia, Hoskin, Peter, Fuller, Donald B, Franzese, C, Franzese, C., Scher, N., Pepa M., Zilli, T., Zerini D., Scher N., Vavassori, A., Fuller, DB, Alongi F., Arcangeli, S, Pieters, BR, Vavassori, Andrea, Alongi, F, De Bari, B, Arcangeli S., De Bari B., Marvaso, G., Janoray, G., Kerkmeijer, L.G.W., Janoray, Guillaume, Scher, N, Franzese C., Toledano A., Marvaso, G, Gugliandolo, S.G., Kerkmeijer L., Marvaso, Giulia, Miralbell, R., Pinkawa, M., Gugliandolo S. G., Tree A. C., van As N., De Bari, B., Scorsetti M., Pieters, B.R., Zilli, T, Zerini, D, Pinkawa, M, Shelan, M, Jereczek-Fossa, BA, Zilli, Thomas, Scher, Nathaliel, Bossi, A, Toledano, A, As, N. van, Pasquier, D, Zaffaroni, M., Miralbell, Raymond, Gandini, S., Arcangeli, Stefano, Tree, A.C.   +152 more
core   +1 more source

Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Hepatocellular Carcinoma Treated with Stereotactic Body Radiotherapy

The Korean Journal of Gastroenterology, 2022
Purpose: To investigate the prognostic value of the neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in patients with hepatocellular carcinoma (HCC) treated with stereotactic body radiotherapy (SBRT).
Younghee Park, Ah Ram Chang
doaj   +1 more source

Integrating Immunotherapy Into Head and Neck Surgery: Bridging Tumor Biology to Perioperative Decision‐Making, a Review

Head &Neck, EarlyView.
ABSTRACT Objective To provide a comprehensive review of the biological rationale, clinical evidence, and practical perioperative management of immunotherapy for the head and neck surgeon. Summary Background Data Standard treatment for resectable head and neck squamous cell carcinoma (HNSCC) has reached a survival plateau, with over 50% of patients ...
Nicholas Brian Shannon, Bruce Ashford
wiley   +1 more source

Knowledge-based models for SBRT prostate treatments

, 2023
<p><span>Two </span><span><span>knowledge-based models (KBP) for SBRT prostate treatments plans are made available. </span></span></p> <p><span>A KBP-model (ST-model) was created from ...
Scaggion, Alessandro
core   +1 more source

Shifting the immune-suppressive to predominant immune-stimulatory radiation effects by sbrt-partial tumor irradiation targeting hypoxic segment (Sbrt-pathy) [PDF]

, 2021
Radiation-induced immune-mediated abscopal effects (AE) of conventional radiotherapy are very rare. Whole-tumor irradiation leads to lymphopenia due to killing of immune cells in the tumor microenvironment, resulting in immunosuppression and weak ...
Hyden, M, Grusch, M, Popper, HH, Brcic, L, Fossati, P, Ashdown, ML, Khleif, SN, Negrini, S, Tubin, S, Gupta, S, Hug, E, Peter-Vörösmarty, B   +11 more
core   +1 more source

Commissioning of the First MRlinac in Latin America

Journal of Medical Physics
Purpose: To show the workflow for the commissioning of a MRlinac, and some proposed tests; off-axis targets, output factors for small fields, dose in inhomogeneities, and multileaf collimator quality assurance (MLC QA).
Rojas-López José Alejandro, Cabrera-Santiago Alexis, González Souto Xesús   +2 more
doaj   +1 more source

SBRT pancreas

, 2022
Introduction: In order to deliver a better and better dose to the region of interest, the SBRT method of pancreatic irradiation was introduced. Goal: Precise delivery of a high dose to a small volume with a small number of fractions. The role of the radiotherapy technician during each segment of the entire process, as well as all the specifics of the ...
openaire   +1 more source

Tumor‐Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy–Immunotherapy Combination Trials

International Journal of Cancer, EarlyView.
ABSTRACT Clinical trials combining radiotherapy (RT) with immune checkpoint blockade (ICB) have shown improved outcomes in only a fraction of patients, and optimal strategies for integrating these modalities remain under intense investigation. With a few exceptions, phase III combination trials have yielded disappointing results.
Xuanwei Zhang, Hui Wang, Weiyan Tang, Kai Kang, Kateryna Onyshchenko, Taotao Huang, Dan Liu, Jianxin Xue, You Lu, Gabriele Niedermann, Ren Luo   +10 more
wiley   +1 more source

Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC. [PDF]

PLoS ONE, 2017
This study aimed to assess the dosimetric differences between iodine-125 seed stereotactic brachytherapy (SBT) and stereotactic body radiation therapy (SBRT) in the treatment of non-small cell lung cancer (NSCLC).
Ranran Li, Ying Zhang, Yuan Yuan, Qi Lin, Jianjian Dai, Ruicai Xu, Xudong Hu, Mingyong Han   +7 more
doaj   +1 more source

Hypervision Proton Surgery: The Future Direction of Proton Therapy

iNew Medicine, EarlyView.
ABSTRACT Proton beams provide unique physical advantages characterized by a low entrance dose, negligible exit dose, and a sharp Bragg peak, which enable superior sparing of normal tissues and support safe dose escalation for improved tumor control. However, conventional photon‐based fractionation remains widely used in proton therapy, where prolonged ...
Li Li, Shuanghu Yuan
wiley   +1 more source